Identification of Somatic Chromosomal Abnormalities in Hypothalamic Hamartoma Tissue at the GLI3 Locus

American Journal of Human Genetics

Volumn 82, Issue 2, 2008, Pages 366-374

  Craig, David W ^a   Itty, Abraham ^a   Panganiban, Corrie ^a   Szelinger, Szabolcs ^a   Kruer, Michael C ^b   Sekar, Aswin ^a   Reiman, David ^a   Narayanan, Vinodh ^c   Stephan, Dietrich A ^a   Kerrigan, John F ^c  

^a TRANSLATIONAL GENOMICS RESEARCH INSTITUTE   (United States)

^b PHOENIX CHILDREN'S HOSPITAL   (United States)

^c BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CHILD; CHROMOSOME 7P; CHROMOSOME ABERRATION; DISEASE ASSOCIATION; DNA ISOLATION; FEMALE; GENE; GENE IDENTIFICATION; GENE LOCUS; GENE MAPPING; GENE MUTATION; GENE SEQUENCE; GENETIC SCREENING; GENOME ANALYSIS; GENOTYPE; GERM LINE; GLI3 GENE; HAMARTOMA; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; HYPOTHALAMIC HAMARTOMA; INFANT; INTRACTABLE EPILEPSY; MAJOR CLINICAL STUDY; MALE; MICROARRAY ANALYSIS; PALLISTER HALL SYNDROME; PATHOGENESIS; PRIORITY JOURNAL; RARE DISEASE; SINGLE NUCLEOTIDE POLYMORPHISM; CHROMOSOME 7; COMPARATIVE STUDY; DNA SEQUENCE; GENETICS; HYPOTHALAMUS DISEASE; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

GLI3 PROTEIN, HUMAN; KRUPPEL LIKE FACTOR; NERVE PROTEIN; PRIMER DNA; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; BASE SEQUENCE; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 7; DNA PRIMERS; GENOTYPE; HAMARTOMA; HUMANS; HYPOTHALAMIC DISEASES; INFANT; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LOSS OF HETEROZYGOSITY; MICROARRAY ANALYSIS; MOLECULAR SEQUENCE DATA; NERVE TISSUE PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS, DNA;

EID: 40749156749     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajhg.2007.10.006     Document Type: Article

References (36)

1. Brandberg G., Raininko R., and Eeg-Olofsson O. Hypothalamic hamartoma with gelastic seizures in Swedish children and adolescents. Eur. J. Paediatr. Neurol. 6 (2004) 35-44
2. Berkovic S.F., Andermann F., Melanson D., Ethier R.E., Feindel W., and Gloor P. Hypothalamic hamartomas and ictal laughter: Evolution of a characteristic epileptic syndrome and diagnostic value of magnetic resonance imaging. Ann. Neurol. 23 (1998) 429-439
3. Valdueza J.M., Cristante L., Dammann O., Bentele K., Vortmeyer A., Saeger W., Padberg B., Freitag J., and Herrmann H.-D. Hypothalamic hamartomas: With special reference to gelastic epilepsy and surgery. Neurosurgery 34 (1994) 949-958
4. Arita K., Ikawa F., Kurisu K., Sumida M., Harada K., Uozumi T., Monden S., Yoshida J., and Nishi Y. The relationship between magnetic resonance imaging findings and clinical manifestations of hypothalamic hamartoma. J. Neurosurg. 91 (1999) 212-220
5. Jung H., Probst E.N., Hauffa B.P., Partsch C.J., and Dammann O. Association of morphological characteristics with precocious puberty and/or gelastic seizures in hypothalamic hamartoma. J. Clin. Endocrinol. Metab. 88 (2003) 4590-4595
6. Deonna T., and Ziegler A.-L. Hypothalamic hamartoma, precocious puberty and gelastic seizures: a special model of "epileptic" developmental disorder. Epileptic Disord. 2 (2000) 33-37
7. Arzimanoglou A.A., Hirsch E., and Aicardi J. Hypothalamic hamartoma and epilepsy in children:illustrative cases of possible evolutions. Epileptic Disord. 5 (2003) 187-199
8. Kerrigan J.F., Ng Y.-t., Chung S.S., and Rekate H.R. The hypothalamic hamartoma: A model of subcortical epileptogenesis and encephalopathy. Semin. Pediatr. Neurol. 12 (2005) 119-131
9. Ng Y.-t., Rekate H.L., Prenger E.C., Chung S.S., Feiz-Erfan I., Wang N.C., Varland M.R., and Kerrigan J.F. Transcallosal resection of hypothalamic hamartoma for intractable epilepsy. Epilepsia 47 (2006) 1192-1202
10. Biesecker L.G. Heritable syndromes with hypothalamic hamartoma and seizures: Using rare syndromes to understand more common disorders. Epileptic Disord. 5 (2003) 235-238
11. Biesecker L.G., Abbott M., Allen J., Clericuzio C., Feuillan P., Graham Jr. J.M., Hall J., Kang S., Olney A.H., Lefton D., et al. Report from the workshop on Pallister-Hall syndrome and related phenotypes. Am. J. Med. Genet. 65 (1996) 76-81
12. Kletter G.B., and Biesecker L.G. Male-to-male transmission of the Pallister-Hall syndrome. Am. J. Hum. Genet. 51 suppl (1992) A100
13. Kang S., Allen J., Graham Jr. J.M., Grebe T., Clericuzio C., Patronas N., Ondry F., Green E., Schaffer A., Abbott M., et al. Linkage mapping and phenotypic analysis of autosomal dominant Pallister-Hall syndrome. J. Med. Genet. 34 (1997) 441-446
14. Kang S., Graham Jr. J.M., Olney A.H., and Biesecker L.G. GLI3 frameshift mutations cause autosomal dominant Pallister-Hall syndrome. Nat. Genet. 15 (1997) 266-268
15. Delalande O., and Fohlen M. Disconnecting surgical treatment of hypothalamic hamartoma in children and adults with refractory epilepsy and proposal of a new classification. Neurol. Med. Chir. (Tokyo) 43 (2003) 61-68
16. Kennedy G.C., Matsuzaki H., Dong S., Liu W.M., Huang J., Liu G., Su X., Cao M., Chen W., Zhang J., et al. Large-scale genotyping of complex DNA. Nat. Biotechnol. 21 (2003) 1233-1237
17. Wang J., Chuang K., Ahluwalia M., Patel S., Umblas N., Mirel D., Higuchi R., and Germer S. High-throughput SNP genotyping by single-tube PCR with Tm-shift primers. Biotechniques 39 (2005) 885-893
18. T method. Methods 25 (2001) 402-408
19. Lin M., Wei L.J., Sellers W.R., Lieberfarb M., Wong W.H., and Li C. dChipSNP: Significance curve and clustering of SNP-array-based loss-of-heterozygosity data. Bioinformatics 20 (2004) 1233-1240
20. Huentelman M.J., Craig D.W., Shieh A.D., Corneveaux J.J., Hu-Lince D., Pearson J.V., and Stephan D.A. SNiPer: Improved SNP genotype calling for Affymetrix 10K GeneChip microarray data. BMC Genomics 6 (2005) 149
21. Leykin I., Hao K., Cheng J., Meyer N., Pollak M.R., Smith R.J., Wong W.H., Rosenow C., and Li C. Comparative linkage analysis and visualization of high-density oligonucleotide SNP array data. BMC Genet. 6 (2005) 7
22. Di X., Matsuzaki H., Webster T.A., Hubbell E., Liu G., Dong S., Bartell D., Huang J., Chiles R., Yang G., et al. Dynamic model based algorithms for screening and genotyping over 100 K SNPs on oligonucleotide microarrays. Bioinformatics 21 (2005) 1958-1963
23. Thorisson G.A., Smith A.V., Krishnan L., and Stein L.D. The International HapMap Project Web site. Genome Res. 15 (2005) 1592-1593
24. Berkovic S.F., Arzimanoglou A., Kuzniecky R., Harvey A.S., Palmini A., and Andermann F. Hypothalamic hamartoma and seizures: A treatable epileptic encephalopathy. Epilepsia 44 (2003) 969-973
25. Wu J., Xu L., Kim D.Y., Rho J.M., St. John P.A., Lue L.-F., Coons S., Ellsworth K., Nowak L., Johnson E., et al. Electrophysiological properties of human hypothalamic hamartomas. Ann. Neurol. 58 (2005) 371-382
26. Fenoglio K.A., Rho J.M., Wu J., Kim D.Y., Simeone T.A., Coons S.W., Rekate H.L., and Kerrigan J.F. Hypothalamic hamartoma: Basic mechanisms of intrinsic epileptogenesis. Semin. Pediatr. Neurol. 14 (2007) 51-59
27. Biesecker L.G. What you can learn from one gene: GLI3. J. Med. Genet. 43 (2006) 465-469
28. Kang S., Rosenberg M., Ko V.D., and Biesecker L.G. Gene structure and allelic expression assay of the human GLI3 gene. Hum. Genet. 101 (1997) 154-157
29. Johnston J.J., Olivos-Glander I., Killoran C., Elson E., Turner J.T., Peters K.F., Abbott M.H., Aughton D.J., Aylsworth A.S., Bamshad M.J., et al. Molecular and clinical analyses of Greig cephalopolysyndactyly and Pallister-Hall syndromes: Robust phenotype prediction from the type and position of GLI3 mutations. Am. J. Hum. Genet. 76 (2005) 609-622
30. Shin S.H., Kogerman P., Lindstrom E., Toftgard R., and Biesecker L.G. GLI3 mutations in human disorders mimic Drosophila cubitus interruptus protein functions and localizations. Proc. Natl. Acad. Sci. USA 96 (1999) 2880-2884
31. Gnarra J.R., Tory K., Weng Y., Schmidt L., Wei M.H., Li H., Latif F., Liu S., Chen F., Duh F.-M., et al. Mutations of the VHL tumour supressor gene in renal carcinoma. Nat. Genet. 7 (1994) 85-90
32. Eng C., Smith D.P., Mulligan L.M., Nagal M.A., Healey C.S., Ponder M.A., Gardner E., Scheumann G.F.W., Jackson C.E., Tunnacliffe A., et al. Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours. Hum. Mol. Genet. 3 (1994) 237-241
33. Hofstra R.M.W., Stelwagen T., Stulp R.P., De Jong D., Hulsbeek M., Kamsteeg E.J., Van Den Berg A., Landsvater R.M., Vermey A., Molenaar W.M., et al. Extensive mutation scanning of RET in sporadic medullary thyroid carcinoma and of RET and VHL in sporadic pheochromocytoma reveals involvement of these genes in only a minority of cases. J. Clin. Endocrinol. Metab. 81 (1996) 2881-2884
34. Maher E.R., and Eng C. The pressure rises: Update on the genetics of pheochromocytoma. Hum. Mol. Genet. 11 (2002) 2347-2354
35. Kelberman D., Rizzoti K., Avilion A., Bitner-Glindzicz M., Cianfarani S., Collins J., Chong W.K., Kirk J.M.W., Achermann J.C., Ross R., et al. Mutations within Sox2/SOX2 are associated with abnormalities in the hypothalamo-pituitary-gonadal axis in mice and humans. J. Clin. Invest. 116 (2006) 2442-2455
36. Kerrigan J.F., Kruer M.C., Corneveaux J., Panganiban C.B., Itty A., Reiman D., Ng Y.-t., Stephan D.A., and Craig D.W. Chromosomal abnormality at 6p25.1-25.3 identifies a susceptibility locus for hypothalamic hamartoma associated with epilepsy. Epilepsy Res. 75 (2007) 70-73